THE EFFECTS OF INTERMITTENT VITAMIN D3 SUPPLEMENTATION ON MUSCLE STRENGHT AND METABOLIC PARAMETERS IN POSTMENOPAUSAL WOMEN WITH TYPE 2 BIABETES: A RANDOMIZED.

Slides:



Advertisements
Similar presentations
Vitamin D: Should a regular dose be part in immunomodulation of regulatory T cells in immunomediated diseases? Gerlies Treiber, Barbara Prietl, Thomas.
Advertisements

1 Baseline BMI and Age-Adjusted Incidence of Diabetes Mellitus White Men Level of BMI Percent
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY (ACCORD)
Clinical case 2003… A 30 year-old woman…...admitted to our hospital due to obesity and diabetes mellitus...
Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcome Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic.
Slide Source: Lipids Online Slide Library 56 healthy premenopausal obese women (aged 25–44 years) compared with 40 age-matched nonobese.
Recovery of the β–cell function both in new and long-standing type 2 diabetic patients through long-term treatment with continuous subcutaneous insulin.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
Effectiveness of Orthoses and Foot Training in patients with Patellofemoral Pain and hyperpronation Mølgaard C. (1+2), Kaalund S.(3), Christensen M.(1),
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Low 25-Hydroxyvitamin D and Risk of Type 2 Diabetes: A Prospective Cohort Study and Meta-analysis S. Afzal, S.E. Bojesen, and B.G. Nordestgaard February.
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
Vitamin D and cardiometabolic disorders  Recent data suggests a connection between vitamin D levels and cardiometabolic diseases: o Obesity o Impaired.
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
CONFIDENTIAL Investor Call December 9, 2010 Claire L. Kruger, Ph.D., Chief Executive Officer Robert A. Lodder, Ph.D., President.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
ALEXA BROOKS DR. SARA JARVIS NORTHERN ARIZONA UNIVERSITY Effects of hyper-hydration on orthostatic tolerance in men and women.
1 The Study of Trandolapril- verapamil And insulin Resistance STAR determined whether glycaemic control was maintained to a greater degree by an RAS inhibitor/non-DHP.
INTRODUCTION  Deficiency of vitamin D is currently a major global health problem, in both adults and children.  This problem is more prevalent in the.
Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus Matthew Faiman.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
Presented by Dr. Soe Sandi Tint
1. Relation between dietary macronutrient and fiber intake with metabolic syndrome in Tehranian adults: Tehran Lipid and Glucose Study Hosseinpour S,
Conclusion In conclusion, preliminary data from this nutrition intervention study suggest that a well balanced Mediterranean-type diet is able to reduce.
A Randomized Placebo- Controlled Trial of Metformin for the Treatment of HIV Lipodystrophy Rakhi Kohli MD MS, Christine Wanke MD, Sherwood Gorbach MD,
Diabetes National Diabetes Control Programme
A Double-Blind, Randomized, Placebo-Controlled Trial of High- Dose Vitamin D Therapy on Musculoskeletal Pain and Bone Mineral Density in Anastrozole- Treated.
Journal Club 亀田メディカルセンター 糖尿病内分泌内科 Diabetes and Endocrine Department, Kameda Medical Center 松田 昌文 Matsuda, Masafumi 2007 年6月 14 日 8:20-8:50 B 棟8階 カンファレンス室.
Farid Saad Euro Weight Loss-2015 Frankfurt, Germany August 18 – 20, 2015.
PREVALENCE OF ORTHOSTATIC HYPERTENSION AND ITS ASSOCIATION WITH METABOLIC AND ECHOCARDIOGRAPHIC PARAMETERS IN ELDERLY PATIENTS WITH TYPE 2 DIABETES INTRODUCTION.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
A Diabetes Outcome Progression Trial
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
VITAMIN D DEFICIENCY IN PREGNANCY AND ITS RELATIONSHIP WITH MATERNAL-FETAL OUTCOMES IN WOMEN LIVING IN THE TROPICS INTRODUCTION Vitamin D deficiency in.
The Diabetic Retinopathy Clinical Research Network Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control (Protocol M) 11.
Higher IGF-1 levels in Black vs White Children: Does Ghrelin Play a Role? Fida Bacha, MD Silva Arslanian, MD Children’s Hospital of Pittsburgh.
CSM-1 Patients With and Without Obesity LSM Difference and 95% CI in BP (230, 231 Pooled) † Diastolic BP Overall (N = 1,191) Obese.
Dr Pulin Kumar Gupta Associate Professor Department of Medicine Incharge HIV/ART Centre PGIMER, Dr RML Hospital NEW DELHI INDIA.
Authors: Dr. Majid Valizadeh Dr. Zahra Piri Dr. Kourosh Kamali Dr. Farnaz Mohammadian Dr. Hamidreza Amirmioghadami Presenter: Piri Z. MD.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
The short term effects of metabolic syndrome and its components on all-cause-cause mortality-the Taipei Elderly Health Examination Cohort Wen-Liang Liu.
DOES LEPTIN LEVELS AFFECT CARDIOMETABOLIC FACTORS INDEPENDENTLY OF ADIPOSITY IN OBESE BRAZILIAN CHILDREN? Maria Edna Melo 1,2,3, Clarissa TH Fujiwara 1,
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
Date of download: 9/17/2016 From: Dose Response to Vitamin D Supplementation in Postmenopausal Women: A Randomized Trial Ann Intern Med. 2012;156(6):
Lacto-ovo vegetarian group
Nivedita Patni MD1, Abhimanyu Garg MD2.
Supplemental Figure 1 A B C D E F
Westerweel PE et al. Eur Heart J 2008;29:
Insulin Resistance and serum Leptin levels in women with Gestational Diabetes Mellitus GÖKÇE ANIK İLHAN Yasemin Emiroğlu Çekiç1, Gökçe Anık İlhan2, Kadir.
Key publication slides
Flowchart of participants
From ESH 2016 | POS 3C: Luiz Aparecido Bortolotto, MD, PhD
Without insulin therapy (n = 14)
Department of Pediatric Newborn Medicine
Insulin resistance in prepubertal children
W.S.T. Swarnasri1, Noel P. Somasundaram2
Ahsan Kazmi, Khalid Mehmood Tariq, Rizwan Hashim
CHAPTER 7 Nutritional Status on Dialysis
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
© The Author(s) Published by Science and Education Publishing.
VK2809 in NAFLD: a phase 2 study
(G) Body mass index (BMI) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (G) Body mass index (BMI) values.
New diabetes stratification
© The Author(s) Published by Science and Education Publishing.
Body Composition and All-Cause Mortality in Hemodialysis Patients
Mean BP by visit - all patients
Presentation transcript:

THE EFFECTS OF INTERMITTENT VITAMIN D3 SUPPLEMENTATION ON MUSCLE STRENGHT AND METABOLIC PARAMETERS IN POSTMENOPAUSAL WOMEN WITH TYPE 2 BIABETES: A RANDOMIZED CONTROLLED STUDY INTRODUCTION The association between vitamin D deficiency and the development of metabolic syndrome and type 2 diabetes as well as decreased skeletal muscle mass has been reported but the effects of vitamin D supplementation on these parameters is still controversial. Baseline characteristics in the intervention and control groups were: age ± 7.62 vs ± 8.00 years (p= 0.9), diabetes duration 11.1 ± 7.4 vs 8.95 ± 7.4 years (p=0.36), BMI 27.6 ± 5.3 vs 28.2 ±5.9 Kg/m 2 (p=0.6), HbA1c 8.18 ± 2.13 vs 9.13 ± 2.12 % (p= 0.15), serum 25OHD ± 3.98 vs ± 4.21 ng/ml (p=0.6), with differences in sun index, BP, FPG, and serum lipids. At the end of treatment period 26% of the intervention and 48% of the control groups had 25OHD < 20 ng/ml. Handgrip strength improved significantly in the intervention group (right arm 17.4 ± 2.68 to 19.9 ± 3.53 Kg, p= 0.002; left arm ± 2.6 to ± 3.2 Kg, p< 0.001) but not in the control group (right arm ± 3.99 to ± 4.91 Kg, p= 0.101; left arm ± 4.29 to ± 4.79 Kg, p = 0.229). There were no significant differences in the distribution of BMI at baseline but more patients in the control group became obese at the end of the study period (p=0.014). There were no significant changes in mean FPG (155.5 ± 67.4 to ± 87.9 mg/dl, p=0.7), PPG ± 87.7 to mg/dl, p=0.8), HbA1c (8.18 ± 2.13 to CONCLUSION Vitamin D3 supplementation in doses equivalent to 942 IU/day improved isometric handgrip strength but had no effect on glycemic control in postmenopausal women with longstanding type 2 diabetes. REFERENCES METHODS 38 patients with serum 25OHD < 30 ng/ml were randomly assigned to oral vitamin D3 (6600IU/week in 2 cc oil preparation) or 2cc olive oil weekly for 3 months with the study medication being administered under supervision in all subjects. Roseane Silva, Luiz Griz, Juliana Maia, Manoel Soares Filho, Maria Paula Bandeira, Francisco Bandeira Division of Endocrinology, Diabetes and Bone Disease, Agamenon Magalhães Hospital, University of Pernambuco Medical School, Recife, Brazil SUN-262 RESULTS OBJECTIVE To evaluate the effect of weekly vitamin D3 supplementation on metabolic parameters and muscle strength of postmenopausal women with type 2 diabetes ± 2.41 %, p=0.1), serum triglycerides ( ± 86.5 to ± mg/dl, p=0.9), SBP (136.3 ± 12.7 to ± 4.2 mmHg, p=0,4) and DBP (81.3 ± 7.4 to 83.0 ± 10.0 mmHg, p=0.4) with vitamin D supplementation. SBP increased significantly in the control group from ± 18.6 to ± 17.6 mmHg (p=0.04). 1- Suzuki A, Kotake M, Ono Y, et al. Hypovitaminosis D in type 2 diabetes mellitus: Association with microvascular complications and type of treatment. Endocrine Journal. 2006;53(4): Palomer X, González-Clemente JM, Blanco-Vaca F, et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes, Obesity and metabolism. 2008;10: Bandeira F, Griz L, Dreyer P, et al. Vitamin D deficiency: a global perspective. Arq Bras Endocrinol Metab. 2006;50(4): Table 1. Caracteristics of study patients DATA EXPRESSED AS MEAN (± SD) FOR CONTINUOUS VARIABLES Figure 1. Handgrip strenght in the right arm before and after vitamin D suplementation Figure 2. Handgrip strenght in the left arm before and after vitamin D suplementation p= p < p = p = 0.229